Peptides are a group of biologically active substances that are involved in various cellular functions of organisms.Peptides are frequently utilized in functional analysis, research on vaccines, and particularly in the production of pharmaceuticals. More than 80 peptide medications are already available on the market to treat a variety of illnesses, such as diabetes, cancer, osteoporosis, multiple sclerosis, HIV infection, and chronic pain.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V85258 | Acetyl angiotensinogen (1-14), porcine | 66641-26-7 | |
![]() |
V36740 | Acetyl-(Ala11·15)-Endothelin-1 (6-21) | 143113-45-5 | BQ-3020 is an endothelin receptor (ETBreceptor) agonist that replaces [125I]ET-1 and binds to porcine cerebellum ETB receptor, with IC50 of 0.2 nM. |
![]() |
V34957 | Acetyl-(Asn30,Tyr32)-Calcitonin (8-32) (salmon I) | 151804-77-2 | AC 187 is a potent and orally bioactive amylin receptor blocker (antagonist) with IC50 of 0.48 nM and Ki of 0.275 nM. |
![]() |
V36845 | Acetyl-(Cys11,D-2-Nal14,Cys18)-β-MSH (11-22) amide | 207678-81-7 | HS014 is a potent and specific melanocortin-4 (MC4) receptor blocker (antagonist) with Kis of 3.16, 108, 54.4 and 694 nM for human MC4, MC1, MC3 and MC5 receptors, respectively. |
![]() |
V36832 | Acetyl-(Cys3,Nle4,Arg5,D-2-Nal7,Cys11)-α-MSH (3-11) amide | 212370-59-7 | HS024 is a selective MC4 receptor blocker (antagonist) with Ki of 0.29, 3.29, 5.45 and 18.6 nM for MC4, MC5, MC3 and MC1 respectively. |
![]() |
V36835 | Acetyl-(Cys4,D-Phe7,Cys10)-α-MSH (4-13) | 91050-39-4 | Acetyl-(Cys4,D-Phe7,Cys10)-α-MSH (4-13) is a peptide compound. |
![]() |
V36844 | Acetyl-(D-Arg10,Cys11,D-Phe14,Cys17)-β-MSH (10-17) amide | 819048-44-7 | Ac-DArg-c[Cys-Glu-His-DPhe-Arg-Trp-Cys]-NH 2 is a cyclic octapeptide with MC4R agonism. |
![]() |
V36840 | Acetyl-(D-Lys11,D-Val13)-α-MSH (11-13) | Acetyl-(D-Lys11,D-Val13)-α-MSH (11-13) is a peptide compound. | |
![]() |
V36551 | Acetyl-(D-Trp1,D-Phe(4-Cl)2,D-Trp3,D-Arg6,D-Ala10)-LHRH | 86044-76-0 | Acetyl-(D-Trp1,D-Phe(4-Cl)2,D-Trp3,D-Arg6,D-Ala10)-LHRH is a peptide compound. |
![]() |
V36841 | Acetyl-(D-Val13)-α-MSH (11-13) | Acetyl-(D-Val13)-α-MSH (11-13) is a peptide compound. | |
![]() |
V36877 | Acetyl-(Leu28·31)-Neuropeptide Y (24-36) | 155709-24-3 | Acetyl-(Leu28·31)-Neuropeptide Y (24-36) is a peptide compound. |
![]() |
V36851 | Acetyl-(Lys0,Nle3)-γ2-MSH amide | 237761-41-0 | Acetyl-(Lys0,Nle3)-γ2-MSH amide is a peptide compound. |
![]() |
V36833 | Acetyl-(Nle4,Asp5,D-Tyr7,Lys10)-cyclo-α-MSH (4-10) amide | 213314-49-9 | Acetyl-(Nle4,Asp5,D-Tyr7,Lys10)-cyclo-α-MSH (4-10) amide is a peptide compound. |
![]() |
V36834 | Acetyl-(Nle4,Gln5,D-Phe7,D-Trp9)-α-MSH (4-10) amide | 172617-89-9 | Acetyl-(Nle4,Gln5,D-Phe7,D-Trp9)-α-MSH (4-10) amide is a peptide compound. |
![]() |
V36461 | Acetyl-(Tyr1,D-Arg2)-GRF (1-29) amide (human) | 93942-91-7 | Acetyl-(D-Arg2)-GRF (1-29) amide (human) is a growth hormone releasing factor (GRF) antagonist. |
![]() |
V36807 | Acetyl-(Tyr1,D-Phe2)-GRF (1-29) amide (human) | Acetyl-(Tyr1,D-Phe2)-GRF (1-29) amide (human) is a peptide compound. | |
![]() |
V34907 | Acetyl-Adhesin (1025-1044) amide | 320350-56-9 | Acetyl-Adhesin (1025-1044) amide is a 20-peptide fragment of the cell surface adhesin of Streptococcus mutans. |
![]() |
V36351 | Acetyl-Amylin (8-37) (human) | 178603-79-7 | Acetyl-Amylin (8-37) (human) is a specific amylin antagonist. |
![]() |
V36352 | Acetyl-Amylin (8-37) (mouse, rat) | 178603-82-2 | Acetyl-Amylin (8-37) (mouse, rat) is a peptide compound. |
![]() |
V34889 | Acetyl-Angiotensin I | 67509-13-1 | Acetyl-Angiotensin I is a peptide compound. |